
- Oncology NEWS International Vol 9 No 11
- Volume 9
- Issue 11
Breast Cancer Stamp Funds $6.7 Million in 2-Year NCI Grants
BETHESDA, Md-Purchasers of the US Postal Service’s breast cancer awareness stamp have funded $6.7 million in 2-year grants to support novel and innovative research into the disease. The National Cancer Institute has given grants to 31 researchers, and a 32nd grant awaits final approval.
BETHESDA, MdPurchasers of the US Postal Services breast cancer awareness stamp have funded $6.7 million in 2-year grants to support novel and innovative research into the disease. The National Cancer Institute has given grants to 31 researchers, and a 32nd grant awaits final approval.
NCI has earmarked its share of money raised by the stamp sales to fund investigators who want to explore areas that are underrepresented in NCIs research portfolio, particularly high-risk projects that have a potential for a high payoff if successful. One of the aims is to develop new methodologies and technologies that will be seeds for future discovery.
Each grant will provide $75,000 a year for 2 years. NCI expects a number of these projects to develop into mature investigations for which the researchers will seek traditional grant funding.
Articles in this issue
almost 25 years ago
Joe & Ali Torre Lead ‘Two Against One’ Prostate Cancer Campaignalmost 25 years ago
Efforts to Reduce Tobacco Deaths May Fail in the Short Termalmost 25 years ago
Data Published for First-Line Irinotecanalmost 25 years ago
Manufacturing Capability a Factor in Success of New Biologicsalmost 25 years ago
Report Finds States Not Using Tobacco Funds for Preventionalmost 25 years ago
NCI Intramural Program Challenged to ‘Reinvent Itself’almost 25 years ago
Surgery Supported for Recurring Colorectal Canceralmost 25 years ago
Human Side of Cancer Offers Insights on Coping With the Diseasealmost 25 years ago
Irinotecan/Etoposide Combination Achieves 65% Overall Response RateNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.